Melatonin was proposed to ameliorate ischemia AKI in diabetes by improving the SIRT1/Nrf2/HO-1 signaling, suggesting that the SIRT1/Nrf2/HO-1 pathway can be a new target in decreasing the oxidative stress in diabetic IRI [132]. This evidence concerns the gene SIRT1 and diabetes mellitus.